Impact of Pharmaceutical Interviews Regarding the Management of Adverse Effects Related to the An… (NCT05248490) | Clinical Trial Compass
CompletedNot Applicable
Impact of Pharmaceutical Interviews Regarding the Management of Adverse Effects Related to the Antibiotic Therapy Used to Treat Osteoarticular Infections During Return Home
France90 participantsStarted 2022-03-22
Plain-language summary
The primary objective is to evaluate the impact of Pharmaceutical Interviews in the patient self-management of non-severe side effects caused by antibiotics prescribed for the treatment of osteoarticular infections when the patient returns home.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient \> or =18 years;
* Informed consent signed;
* French-speaking and reading;
* Affiliated to a social insurance;
* Benefiting from medical and surgical care for an osteoarticular infection;
* Treated with an oral antibiotic therapy on discharge from hospital.
* Indication of the antibiotic therapy osteoarticular infection;
* Return home immediately after discharge.
Exclusion Criteria:
* Refusal to participate
* Protected adult patient, under guardianship or curatorship.
* Minor patient
* Patient benefiting from an AME.
* Pregnant or breastfeeding woman.
* Non-French speaking patient.
* Patient unable to understand the course of the study.
* Patient with a documented history of cognitive or psychiatric disorders.
* Patient treated with oral antibiotic therapy for an indication other than osteoarticular infection.
* Patient treated with parenteral antibiotic therapy.
* Discharge: Institution (EHPAD), rehabilitation or other health establishment.
* Patient systematically using one of the symptomatic treatments proposed in the discharge prescription before hospitalization.